查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1466427

基因合成市場：依產品、方法、基因型、應用和最終用途 - 2024-2030 年全球預測

Gene Synthesis Market by Product (Hardware, Services, Software), Method (Chip-Based Synthesis, PCR-Based Enzyme Synthesis, Solid-Phase Synthesis), Gene Type, Application, End-use - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年基因合成市場規模為42.4億美元，2024年達46.8億美元，2030年預計將達87億美元，複合年成長率為10.82%。

基因合成市場包括與研究、醫學、農業和生物技術等各行業透過化學方法人工創建 DNA 序列相關的技術、產品和服務。典型的最終用戶包括學術機構、製藥和生物技術公司、政府機構和委外研發機構(CRO)。全球人口中慢性病盛行率的不斷上升、對個人化藥物的需求不斷增加，以及基因組研究的進步正在推動這一市場的發展。此外，基因合成相對於傳統方法的優勢正在推動市場成長。然而，諸如規範基因改造作物開發和商業化的嚴格法規以及對合成基因的大小和複雜性的限制等技術挑戰限制了基因合成市場的成長。提高效率和精度的基因合成新技術以及基因合成在能源和農業領域的廣泛應用正在為市場創造巨大的成長機會。

主要市場統計
基準年[2023] 42.4億美元
預測年份 [2024] 46.8億美元
預測年份 [2030] 87億美元
複合年成長率（%） 10.82%

擴大支持產品合成基因精確設計的軟體的使用

基因合成硬體，包括寡核苷酸合成器，是合成 DNA 和 RNA 短片段（稱為寡核苷酸）的專用設備。這些合成器在基因合成的早期階段至關重要，可以創建組裝成更長基因序列的構建塊。基因定序儀對於此目的至關重要，它提供高通量和準確的定序能力，以確保合成基因符合預期設計。自動液體處理系統用於在移液、稀釋和混合組裝和擴增步驟所需的試劑和寡核苷酸期間減少錯誤並提高通量。基因合成服務涉及生產可自訂的合成 DNA 序列，以滿足特定的研究或工業要求。這些服務對於蛋白質生產、抗體工程、疫苗開發和生質燃料研究等各種應用至關重要。對自訂基因的需求不斷成長，導致越來越多的服務供應商提供基因合成的端到端解決方案。該軟體解決方案專為合成基因設計和模擬而設計。這些工具使研究人員和生物技術人員能夠透過最佳化密碼子使用偏差、RNA 二級結構預測、GC 含量和限制性內切酶位點避免等因素來簡化他們的工作流程。此外，基因合成軟體可降低 DNA 從頭合成過程中出現錯誤的風險，有助於提高研究效率並最大限度地降低成本。

方法 提高大型計劃中基於晶片的合成的利用率

基於晶片的合成使用微陣列或生物晶片在小玻片上同時合成數千種寡核苷酸。這種高通量方法適用於需要多個基因的大型計劃或當成本效率很重要時。基於 PCR 的酵素合成使用 DNA聚合酵素等酶，透過連續幾輪的 PCR 擴增將短寡核苷酸組裝成全長基因。這種方法提供快速的周轉時間，非常適合專注於單一基因或基因變異的小型計劃。固相合成將核苷酸依序付加固定在撐體上的不斷生長的 DNA 鏈中。此方法保真度高，並且可以產生比其他方法錯誤更少的長 DNA 序列。基於晶片的綜合非常適合需要成本效率的大型計劃。基於 PCR 的酶合成非常適合專注於單基因或基因變異的小型計劃，其中快速週轉時間至關重要，而固相合成需要高保真度和長 DNA 序列時則首選。

基因型表現基因合成具有越來越大的潛力，為時間敏感的計劃提供快速獲取短基因的途徑。

複雜基因合成專注於創建包含挑戰性序列的合成基因，例如高 GC 含量、串聯重複序列和同聚物區域。疫苗開發、途徑工程和酵素最佳化等治療應用的高級研究需要這些基因。 Express Gene Synthesis 適合需要快速週轉時間進行小型計劃和概念驗證研究的科學家。與其他類型的基因合成相比，合成基因的長度短，傳遞時間短。標準基因合成使用多種技術，包括寡核苷酸組裝和糾錯，來合成高品質、無錯誤的 DNA 序列。此產品類型最常用於常規分子生物學計劃，包括克隆、表達分析和重組蛋白生產。

最終用途生物技術和製藥公司越來越關注創新藥物發現和治療方法開發。

學術機構和政府研究機構由於專注於基礎研究、治療開發和基因工程的進步，對基因合成市場的需求做出了重大貢獻。這些研究機構使用基因合成服務來產生自訂DNA 序列、設計生物途徑和目標基因修飾。生物技術和製藥公司嚴重依賴基因合成服務來推進藥物發現、治療方法開發和精準醫療。自訂基因促進蛋白質表現研究、新藥物標靶的鑑定以及疾病特異性動物模型的開發。受託研究機構已成為基因合成服務的重要最終用戶，為生物製藥和學術客戶提供基因庫建設、自訂克隆和蛋白質表現最佳化方面的支援。生物技術和製藥公司由於專注於創新藥物發現和治療開發而佔據最大佔有率。學術和政府研究機構也紛紛效仿，並專注於基因工程的基礎研究和進展。透過提供滿足各行業不同客戶需求的全面基因組學解決方案，CRO 正經歷快速成長。

基因型：越來越多的機會表達針對特定宿主生物體中高水平表達而最佳化的基因。

複雜基因的特徵是其核苷酸序列複雜，通常含有高GC含量、重複序列和容易產生二級結構的序列。這種複雜性可能會給合成過程和隨後的克隆帶來挑戰。具有長均聚物運作或編碼剪接位點的基因也可以被認為是複雜的。合成複雜的基因需要先進的技術和精心的設計，以確保最終產品的保真度和功能性。表達基因是指經最佳化以在特定宿主生物體中高水平表達的合成產生的DNA序列。這些基因變體通常會經歷密碼子最佳化，即更改密碼子以匹配表達系統的首選用途，並導致 mRNA 更有效地翻譯為蛋白質。此外，可以將強啟動子、增強子和其他調控元件付加到表達的基因中，以促進研究或工業酵素應用的蛋白質生產。標準基因是合成的 DNA 序列，是基因合成服務的基本產品。該基因不具有複雜基因中的複雜性，且未針對涉及表達基因的過度表現進行最佳化。相反，標準基因為研究人員提供了一種準確、可靠且經濟高效的方法來獲取反映天然 DNA 序列或包含微小修飾的 DNA 序列，以用於克隆和功能分析。標準基因是許多基因工程計劃的支柱，廣泛應用於生命科學的各個領域。

區域洞察

由於發達的醫療保健部門和支持性政府計劃的存在，美洲的基因合成市場高度發展。這是由於研發設施的改善、可支配收入的增加和經濟狀況的快速發展。此外，聯邦機構和當局還推出了多項舉措、計劃和計劃，以鼓勵該地區的基因治療研究，形成美洲基因合成的平台。印度、中國、新加坡和馬來西亞等新興國家由於醫療保健標準的提高而具有市場擴張的潛力。國內基因合成製造商在這些經濟體中佔有重要地位，有助於大型跨國企業快速滲透市場。慢性病的流行、技術的進步和醫療基礎設施的改善是推動歐洲、中東和非洲基因合成市場的關鍵原因。該地區各國政府繼續投資基因治療，從而擴大了各種基因合成的使用。 2022年2月，荷蘭政府投資5,504萬美元建造一座新的國家試點工廠，以推進有前景的細胞和基因療法的開發和製造。荷蘭政府的投資預計將為細胞和基因治療公司提供巨大的機會。

FPNV定位矩陣

FPNV定位矩陣對於評估基因合成市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對基因合成市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告在以下方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4. 競爭評估和情報：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1. 基因合成市場的市場規模與預測是多少？

2.在基因合成市場的預測期間內，有哪些產品、細分市場、應用和領域需要考慮投資？

3.基因合成市場的技術趨勢與法規結構是什麼？

4.基因合成市場主要廠商的市場佔有率是多少？

5. 進入基因合成市場的合適型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界人口慢性病盛行率
      • 基因組研究活動的增加和對個人化醫療的日益關注
      • 增加私營和公共部門對藥物研究的投資
    • 抑制因素
      • 基因合成的嚴格監管以及與該過程相關的高成本
    • 機會
      • 基因合成新技術
      • 基因合成在能源和農業產業的利用
    • 任務
      • 合成基因的大小和複雜性的限制
  • 市場區隔分析
    • 產品：擴大軟體的使用範圍以準確設計合成基因
    • 方式：在大型計劃中增加基於晶片的綜合的使用
    • 基因分型：增加快速基因合成的潛力，以便為時間敏感的計劃快速獲取短基因
    • 最終用途：生物技術和製藥公司越來越關注創新藥物發現和治療開發
    • 基因型：為在特定宿主生物體中高水平表達而最佳化的表達基因的生長潛力
  • 市場趨勢分析
    • 持續的技術進步加速了合成基因的生產，以及美洲地區領先公司的強大影響力
    • 亞太地區生物技術和製藥領域的研發活動活躍，合成基因應用需求不斷成長
    • 政府支持在歐洲、中東和非洲地區推廣基因組計劃和基因合成在農業的應用
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法規結構分析

第6章 基因合成市場：依產品

  • 硬體
  • 服務
  • 軟體

第7章 基因合成市場：依方法分類

  • 基於晶片的合成
  • 基於PCR的酶合成
  • 固相合成

第8章 基因合成市場：依基因類型

  • 複雜基因
  • 表達基因
  • 標準基因

第9章基因合成市場：依應用分類

  • 疾病診斷
  • 基因/細胞療法的發展
  • 疫苗開發

第10章基因合成市場：依最終用途

  • 學術和政府研究機構
  • 生物技術和製藥公司
  • 合約研究組織

第11章 北美和南美基因合成市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太基因合成市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章 歐洲、中東和非洲基因合成市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Evonetix 和 Analog Devices Inc 開發創新基因合成平台
    • Gyros Protein Technologies 和 Biotage 聯手透過新的自動化解決方案提高勝胜肽精製效率
    • Synprogen 和 Gingo Bioworks 宣布計劃在日本加速全球 DNA 製造和基因治療平台服務
    • Twist Bioscience 推出 Express Genes 快速基因合成服務
    • 生技公司完成 560 萬英鎊種子輪資金籌措
    • 布魯克以 1.08 億美元收購 Phenomex
    • 系列資金支持 DNA 合成技術的擴展
    • NunaBio 籌集 190 萬英鎊種子資金以擴大基礎設施並加速研發
    • Elegen推出高速長鏈DNA合成儀ENFINIA DNA，促進生物經濟
    • Ansa Biotechnologies 宣布成功合成新型 1005 鹼基寡核苷酸
    • 金斯瑞擴大在新加坡的業務範圍，提供優質基因合成服務
    • Evonetix 完成 2,400 萬美元資金籌措
    • 基因合成（端到端）Barcode Biosciences 在印度啟動銷售
    • Eurofins Genomics Blue Heron推出IVT mRNA合成服務：基因表現的未來

第15章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-3A2E844FEB5F

[181 Pages Report] The Gene Synthesis Market size was estimated at USD 4.24 billion in 2023 and expected to reach USD 4.68 billion in 2024, at a CAGR 10.82% to reach USD 8.70 billion by 2030.

The gene synthesis market comprises technologies, products, and services related to the artificial creation of DNA sequences through chemical methods in various industries such as research, medicine, agriculture, and biotechnology. Key end-users include academic institutions, pharmaceutical and biotechnology companies, government agencies, and contract research organizations (CROs). The growing prevalence of chronic conditions among the global population and rising demand for personalized medicines, along with advancements in genomics research, are driving this market. Moreover, the advantage of gene synthesis over traditional methods is fueling market growth. However, strict regulations governing the development and commercialization of GMOs and technical challenges such as limitations in size and complexity of synthetic genes limit the growth of the gene synthesis market. Emerging technologies in gene synthesis for efficiency and accuracy and the growing utilization of gene synthesis in energy and agriculture industries are creating significant growth opportunities in the market.

KEY MARKET STATISTICS
Base Year [2023] USD 4.24 billion
Estimated Year [2024] USD 4.68 billion
Forecast Year [2030] USD 8.70 billion
CAGR (%) 10.82%

Product: Expanding usage of software that helps design synthetic genes accurately

Gene synthesis hardware, including oligonucleotide synthesizers, are specialized instruments used for the synthesis of short DNA or RNA fragments called oligonucleotides. These synthesizers are essential in the initial steps of gene synthesis, creating the building blocks that will be assembled into longer gene sequences. Gene sequencers are critical for this purpose, providing high-throughput and accurate sequencing capabilities to ensure the synthetic genes match the intended design. Automated liquid handling systems are employed to reduce errors and increase throughput during the pipetting, dilution, and mixing of reagents and oligonucleotides necessary for assembly and amplification steps. Gene synthesis services involve the production of synthetic DNA sequences that can be customized to cater to specific research or industrial requirements. These services are essential for various applications such as protein production, antibody engineering, vaccine development, and biofuel research. The growing demand for custom-made genes has led to an increase in service providers offering end-to-end solutions in gene synthesis. Software solutions are designed specifically for designing and simulating synthetic genes. These tools allow researchers and biotechnologists to streamline their workflow by optimizing factors such as codon usage bias, RNA secondary structure prediction, GC content, and restriction enzyme site avoidance. Moreover, gene synthesis software helps reduce the risk of errors during de novo DNA synthesis, thereby improving research efficiency and minimizing costs.

Method: Rising utilization of chip-based synthesis for large-scale projects

Chip-based synthesis uses microarrays or biochips to synthesize thousands of oligonucleotides simultaneously on a small glass slide. This high-throughput method is suitable for large-scale projects requiring multiple genes or when cost-efficiency is crucial. PCR-based enzyme synthesis involves using enzymes such as DNA polymerase to assemble short overlapping oligonucleotides into full-length genes through consecutive rounds of PCR amplification. This method offers quick turnaround times and is ideal for small-scale projects focusing on single genes or gene variants. Solid-phase synthesis involves sequentially adding nucleotides to a growing DNA chain immobilized on a solid support. This method offers high fidelity and can generate long DNA sequences with fewer errors than other methods. Chip-based synthesis is best suited for large-scale projects requiring cost efficiency. PCR-based enzyme synthesis is ideal when rapid turnaround times are essential for small-scale projects focusing on single genes or gene variants, while solid-phase synthesis is preferred when high fidelity and longer DNA sequences are required.

Gene Type: Growing potential for express gene synthesis that provides quick access to shorter genes for time-sensitive projects

Complex gene synthesis focuses on creating synthetic genes that contain challenging sequences, such as high GC content, tandem repeats, and homopolymeric regions. Scientists often require these genes for advanced research in therapeutic applications such as vaccine development, pathway engineering, and enzymatic optimization. Express gene synthesis caters to scientists who require fast turnaround times for small-scale projects or proof-of-concept studies. These synthesized genes are shorter in length and have a quicker turnaround time compared to other types of gene synthesis. Standard gene synthesis involves the synthesis of high-quality, error-free DNA sequences using a variety of techniques, including oligonucleotide assembly and error correction. This type is most commonly used in routine molecular biology projects involving cloning, expression analysis, and recombinant protein production.

End-use: Increasing focus on innovative drug discovery and therapeutic development across biotechnology and pharmaceutical companies

Academic and government research institutes significantly contribute to gene synthesis market demand because they focus on basic research, therapeutic development, and genetic engineering advancements. These institutes utilize gene synthesis services to generate custom DNA sequences, design biological pathways, and perform targeted gene modifications. Biotechnology and pharmaceutical companies rely heavily on gene synthesis services for drug discovery, therapeutic development, and precision medicine advancements. Custom genes facilitate protein expression studies, identification of novel drug targets, and development of disease-specific animal models. Contract research organizations have emerged as vital end-users of gene synthesis services, supporting biopharmaceutical and academic clients in gene library construction, custom cloning, and protein expression optimization. Biotechnology and pharmaceutical companies command the largest share due to their focus on innovative drug discovery and therapeutic development. Academic government research institutes follow closely, emphasizing fundamental research and genetic engineering advancements. CROs are experiencing rapid growth by offering comprehensive genomics solutions that cater to diverse client demands across industries.

Gene Type: Growing potential of express genes that are optimized for high levels of expression in specific host organisms

Complex genes are characterized by their intricate nucleotide sequences, which often include high GC content, repeated sequences, or sequences prone to secondary structures. Such complexities can pose challenges during the synthesis process and subsequent cloning. Genes with long homopolymeric runs or cryptic splice sites are also considered complex. Synthesizing complex genes requires advanced techniques and careful design to ensure the fidelity and functionality of the final product. Express genes refer to synthetically manufactured DNA sequences optimized for high levels of expression in specific host organisms. These gene variants usually undergo codon optimization, where codons are modified to match the preferred usage of the expression system, leading to more efficient translation of the mRNA into proteins. Additionally, express genes can be outfitted with strong promoters, enhancers, and other regulatory elements to boost protein production for research or industrial enzyme applications. Standard genes are synthetic DNA sequences that represent the basic offering in gene synthesis services. The genes do not possess the complexities found in complex genes and are not optimized for overexpression, including express genes. Instead, standard genes provide researchers with accurate, reliable, and cost-effective means to obtain DNA sequences that are reflective of the native DNA sequence or include slight modifications for cloning or functional analysis. Standard genes are the backbone of many genetic engineering projects and are widely used across different domains of life sciences.

Regional Insights

The gene synthesis market in the Americas is highly developing owing to the presence of a developed healthcare sector and supportive government programs, which has resulted in considerable product development and the commercialization of gene synthesis technologies in the United States and Canada. This is attributed to growing improvements in R&D facilities, available disposable income, and rapidly developing economic conditions. Moreover, federal agencies and authorities have launched several initiatives, programs, and schemes to encourage gene therapy research in the region, creating a platform for gene synthesis in the Americas. Emerging economies such as India, China, Singapore, and Malaysia are potential markets for market expansion due to improved healthcare standards. These economies have a considerable presence of domestic manufacturers of gene synthesis, which contributes to an upsurge in the market penetration of multinational giants. The growing prevalence of chronic diseases, increasing technological advancements, and improved healthcare infrastructure are the primary reasons driving the gene synthesis market in EMEA. Governments across the region have been continuously investing in gene therapies, thereby expanding the utilization of various gene syntheses. In February 2022, the Dutch government invested USD 55.04 million to build a new national pilot factory to advance the development and manufacturing of promising cell and gene therapies. The investment by the Dutch government is expected to provide excellent opportunities for cell and gene therapy companies.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Gene Synthesis Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Gene Synthesis Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Gene Synthesis Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Ansa Biotechnologies, Inc., Applied Biological Materials Inc., AstraZeneca PLC, Azenta, Inc., Barcode Biosciences Private Limited, BGI Genomics by BGI Group, BioCat GmbH by AddLife AB, Biomatik Corporation, Bioneer Corporation, Biotage AB, Biotech Desk Pvt. Ltd., Boster Biological Technology, Brooks Automation Inc., Camena Bioscience, Charles River Laboratories International, Inc., Constructive Bio Ltd, Creative Biogene, Danaher Corporation, DNA TwoPointO Inc., Elabscience Biotechnology Inc., Elegen Corp., Eurofins Scientific SE, Evonetix Ltd., GenCefe Biotech Limited, Gene Universal, Inc., General Biosystems, Inc., GenScript Biotech Corporation, Ginkgo Bioworks Holdings, Inc., Macrogen, Inc., Merck KGaA, NZYTech, Lda., OriGene Technologies, Inc., ProMab Biotechnologies, Inc., ProteoGenix SAS, QIAGEN N.V., Synbio Technologies LLC, Telesis Bio Inc., Thermo Fisher Scientific Inc., and Twist Bioscience Corporation.

Market Segmentation & Coverage

This research report categorizes the Gene Synthesis Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Hardware
    • Services
      • Antibody DNA Synthesis
      • Viral DNA Synthesis
    • Software
  • Method
    • Chip-Based Synthesis
    • PCR-Based Enzyme Synthesis
    • Solid-Phase Synthesis
  • Gene Type
    • Complex Gene
    • Express Gene
    • Standard Gene
  • Application
    • Disease Diagnosis
    • Gene & Cell Therapy Development
    • Vaccine Development
  • End-use
    • Academic & Government Research Institutes
    • Biotechnology & Pharmaceutical Companies
    • Contract Research Organizations
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Gene Synthesis Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Gene Synthesis Market?

3. What are the technology trends and regulatory frameworks in the Gene Synthesis Market?

4. What is the market share of the leading vendors in the Gene Synthesis Market?

5. Which modes and strategic moves are suitable for entering the Gene Synthesis Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of chronic conditions among the global population
      • 5.1.1.2. Increasing genomics research activities and rising focus on personalized medicines
      • 5.1.1.3. Growing investments by the private and public sectors in pharmaceutical research
    • 5.1.2. Restraints
      • 5.1.2.1. Strict regulations governing gene synthesis and high cost associated with the process
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging new technologies in gene synthesis
      • 5.1.3.2. Utilization of gene synthesis in energy and agriculture industries
    • 5.1.4. Challenges
      • 5.1.4.1. Limitations in size and complexity of synthetic genes
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Expanding usage of software that helps design synthetic genes accurately
    • 5.2.2. Method: Rising utilization of chip-based synthesis for large-scale projects
    • 5.2.3. Gene Type: Growing potential for express gene synthesis that provides quick access to shorter genes for time-sensitive projects
    • 5.2.4. End-use: Increasing focus on innovative drug discovery and therapeutic development across biotechnology and pharmaceutical companies
    • 5.2.5. Gene Type: Growing potential of express genes that are optimized for high levels of expression in specific host organisms
  • 5.3. Market Trend Analysis
    • 5.3.1. Ongoing technological advancements to increase the speed of synthetic gene production coupled with a strong foothold of major players in the Americas region
    • 5.3.2. Robust R&D activities in biotechnology and pharmaceutical sectors and the rising need for synthetic gene applications in the Asia-Pacific
    • 5.3.3. Supportive government initiatives for genomic projects and advancing use of gene synthesis in agricultural sector in EMEA
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework Analysis

6. Gene Synthesis Market, by Product

  • 6.1. Introduction
  • 6.2. Hardware
  • 6.3. Services
  • 6.4. Software

7. Gene Synthesis Market, by Method

  • 7.1. Introduction
  • 7.2. Chip-Based Synthesis
  • 7.3. PCR-Based Enzyme Synthesis
  • 7.4. Solid-Phase Synthesis

8. Gene Synthesis Market, by Gene Type

  • 8.1. Introduction
  • 8.2. Complex Gene
  • 8.3. Express Gene
  • 8.4. Standard Gene

9. Gene Synthesis Market, by Application

  • 9.1. Introduction
  • 9.2. Disease Diagnosis
  • 9.3. Gene & Cell Therapy Development
  • 9.4. Vaccine Development

10. Gene Synthesis Market, by End-use

  • 10.1. Introduction
  • 10.2. Academic & Government Research Institutes
  • 10.3. Biotechnology & Pharmaceutical Companies
  • 10.4. Contract Research Organizations

11. Americas Gene Synthesis Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Gene Synthesis Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Gene Synthesis Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Evonetix and Analog Devices Inc To Progress Revolutionary Gene Synthesis Platform
    • 14.3.2. Gyros Protein Technologies and Biotage Partner to Advance Peptide Purification Efficiency With New Automated Solution
    • 14.3.3. Synplogen and Ginkgo Bioworks Announce Plans to Accelerate Global DNA Manufacturing and Gene Therapy Platform Services in Japan
    • 14.3.4. Twist Bioscience Launches Express Genes Rapid Gene Synthesis Service
    • 14.3.5. Biotech Firm Closes GBP 5.6 million Seed Financing
    • 14.3.6. Bruker to Buy PhenomeX For USD 108 Million
    • 14.3.7. Series Funding to Support Expansion of DNA Synthesis Technology
    • 14.3.8. NunaBio Raises GBP 1.9M In Seed Funding To Expand Infrastructure And Accelerate R&D
    • 14.3.9. Elegen Launches ENFINIA DNA, Rapid Long DNA Synthesis to Power the Bioeconomy
    • 14.3.10. Ansa Biotechnologies Announces Successful de novo Synthesis of Oligonucleotide at 1005 Bases
    • 14.3.11. GenScript Expands Footprint in Singapore to Provide Premium Gene Synthesis Service
    • 14.3.12. Evonetix Closes USD 24 million Financing
    • 14.3.13. Gene Synthesis (End-to-End) Now In India At Barcode Biosciences
    • 14.3.14. Eurofins Genomics Blue Heron launches IVT mRNA Synthesis Service: The Future of Gene Expression

15. Competitive Portfolio

  • 15.1. Key Company Profiles
  • 15.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. GENE SYNTHESIS MARKET RESEARCH PROCESS
  • FIGURE 2. GENE SYNTHESIS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GENE SYNTHESIS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL GENE SYNTHESIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GENE SYNTHESIS MARKET DYNAMICS
  • FIGURE 7. GLOBAL GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL GENE SYNTHESIS MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL GENE SYNTHESIS MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL GENE SYNTHESIS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 16. GLOBAL GENE SYNTHESIS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. GENE SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 26. GENE SYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GENE SYNTHESIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GENE SYNTHESIS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL GENE SYNTHESIS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL GENE SYNTHESIS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL GENE SYNTHESIS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL GENE SYNTHESIS MARKET SIZE, BY HARDWARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL GENE SYNTHESIS MARKET SIZE, BY HARDWARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL GENE SYNTHESIS MARKET SIZE, BY SERVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL GENE SYNTHESIS MARKET SIZE, BY SERVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL GENE SYNTHESIS MARKET SIZE, BY ANTIBODY DNA SYNTHESIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL GENE SYNTHESIS MARKET SIZE, BY ANTIBODY DNA SYNTHESIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL GENE SYNTHESIS MARKET SIZE, BY VIRAL DNA SYNTHESIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL GENE SYNTHESIS MARKET SIZE, BY VIRAL DNA SYNTHESIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL GENE SYNTHESIS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL GENE SYNTHESIS MARKET SIZE, BY SOFTWARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL GENE SYNTHESIS MARKET SIZE, BY CHIP-BASED SYNTHESIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL GENE SYNTHESIS MARKET SIZE, BY CHIP-BASED SYNTHESIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL GENE SYNTHESIS MARKET SIZE, BY PCR-BASED ENZYME SYNTHESIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL GENE SYNTHESIS MARKET SIZE, BY PCR-BASED ENZYME SYNTHESIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL GENE SYNTHESIS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL GENE SYNTHESIS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL GENE SYNTHESIS MARKET SIZE, BY COMPLEX GENE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL GENE SYNTHESIS MARKET SIZE, BY COMPLEX GENE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL GENE SYNTHESIS MARKET SIZE, BY EXPRESS GENE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL GENE SYNTHESIS MARKET SIZE, BY EXPRESS GENE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL GENE SYNTHESIS MARKET SIZE, BY STANDARD GENE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL GENE SYNTHESIS MARKET SIZE, BY STANDARD GENE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL GENE SYNTHESIS MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL GENE SYNTHESIS MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GENE & CELL THERAPY DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GENE & CELL THERAPY DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL GENE SYNTHESIS MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL GENE SYNTHESIS MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL GENE SYNTHESIS MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL GENE SYNTHESIS MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL GENE SYNTHESIS MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL GENE SYNTHESIS MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL GENE SYNTHESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL GENE SYNTHESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 57. AMERICAS GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 58. AMERICAS GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 59. AMERICAS GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 60. AMERICAS GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 63. AMERICAS GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 64. AMERICAS GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 65. AMERICAS GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 66. AMERICAS GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 67. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 68. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 69. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 70. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 71. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 72. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 73. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 74. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 75. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 76. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 77. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 78. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 79. BRAZIL GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 80. BRAZIL GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 81. BRAZIL GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 82. BRAZIL GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 83. BRAZIL GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 84. BRAZIL GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 85. BRAZIL GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 86. BRAZIL GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 87. BRAZIL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 88. BRAZIL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 89. BRAZIL GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 90. BRAZIL GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 91. CANADA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 92. CANADA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 93. CANADA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 94. CANADA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 95. CANADA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 96. CANADA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 97. CANADA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 98. CANADA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 99. CANADA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 100. CANADA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 101. CANADA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 102. CANADA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 103. MEXICO GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 104. MEXICO GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 105. MEXICO GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 106. MEXICO GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 107. MEXICO GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 108. MEXICO GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 109. MEXICO GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 110. MEXICO GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 111. MEXICO GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 112. MEXICO GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 113. MEXICO GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 114. MEXICO GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 115. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 116. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 117. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 118. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 119. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 120. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 121. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 122. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 123. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 124. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 125. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 126. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 127. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 128. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 143. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 144. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 145. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 146. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 147. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 148. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 149. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 150. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 151. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 152. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 153. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 154. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 155. CHINA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 156. CHINA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 157. CHINA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 158. CHINA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 159. CHINA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 160. CHINA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 161. CHINA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 162. CHINA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 163. CHINA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 164. CHINA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 165. CHINA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 166. CHINA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 167. INDIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 168. INDIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 169. INDIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 170. INDIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 171. INDIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 172. INDIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 173. INDIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 174. INDIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 175. INDIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 176. INDIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 177. INDIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 178. INDIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 179. INDONESIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 180. INDONESIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 181. INDONESIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 182. INDONESIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 183. INDONESIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 184. INDONESIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 185. INDONESIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 186. INDONESIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 187. INDONESIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 188. INDONESIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 189. INDONESIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 190. INDONESIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 191. JAPAN GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 192. JAPAN GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 193. JAPAN GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 194. JAPAN GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 195. JAPAN GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 196. JAPAN GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 197. JAPAN GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 198. JAPAN GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 199. JAPAN GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 200. JAPAN GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 201. JAPAN GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 202. JAPAN GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 203. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 204. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 205. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 206. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 207. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 208. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 209. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 210. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 211. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 212. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 213. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 214. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 215. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 216. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 217. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 218. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 219. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 220. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 221. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 222. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 223. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 224. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 225. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 226. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 227. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 228. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 229. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 230. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 231. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 232. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 233. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 234. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 235. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 236. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 237. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 238. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 239. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 240. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 241. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 242. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 243. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 244. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 245. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 246. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 247. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 248. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 249. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 250. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 251. TAIWAN GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 252. TAIWAN GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 253. TAIWAN GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 254. TAIWAN GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 255. TAIWAN GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 256. TAIWAN GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 257. TAIWAN GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 258. TAIWAN GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 259. TAIWAN GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 260. TAIWAN GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 261. TAIWAN GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 262. TAIWAN GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 263. THAILAND GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 264. THAILAND GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 265. THAILAND GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 266. THAILAND GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 267. THAILAND GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 268. THAILAND GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 269. THAILAND GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 270. THAILAND GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 271. THAILAND GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 272. THAILAND GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 273. THAILAND GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 274. THAILAND GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 275. VIETNAM GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 276. VIETNAM GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 277. VIETNAM GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 278. VIETNAM GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 279. VIETNAM GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 280. VIETNAM GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 281. VIETNAM GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 282. VIETNAM GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 283. VIETNAM GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 284. VIETNAM GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 285. VIETNAM GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 286. VIETNAM GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 301. DENMARK GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 302. DENMARK GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 303. DENMARK GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 304. DENMARK GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 305. DENMARK GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 306. DENMARK GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 307. DENMARK GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 308. DENMARK GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 309. DENMARK GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 310. DENMARK GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 311. DENMARK GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 312. DENMARK GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 313. EGYPT GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 314. EGYPT GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 315. EGYPT GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 316. EGYPT GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 317. EGYPT GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 318. EGYPT GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 319. EGYPT GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 320. EGYPT GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 321. EGYPT GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 322. EGYPT GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 323. EGYPT GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 324. EGYPT GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 325. FINLAND GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 326. FINLAND GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 327. FINLAND GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 328. FINLAND GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 329. FINLAND GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 330. FINLAND GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 331. FINLAND GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 332. FINLAND GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 333. FINLAND GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 334. FINLAND GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 335. FINLAND GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 336. FINLAND GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 337. FRANCE GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 338. FRANCE GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 339. FRANCE GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 340. FRANCE GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 341. FRANCE GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 342. FRANCE GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 343. FRANCE GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 344. FRANCE GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 345. FRANCE GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 346. FRANCE GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 347. FRANCE GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 348. FRANCE GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 349. GERMANY GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 350. GERMANY GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 351. GERMANY GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 352. GERMANY GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 353. GERMANY GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 354. GERMANY GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 355. GERMANY GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 356. GERMANY GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 357. GERMANY GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 358. GERMANY GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 359. GERMANY GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 360. GERMANY GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 361. ISRAEL GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 362. ISRAEL GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 363. ISRAEL GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 364. ISRAEL GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 365. ISRAEL GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 366. ISRAEL GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 367. ISRAEL GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 368. ISRAEL GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 369. ISRAEL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 370. ISRAEL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 371. ISRAEL GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 372. ISRAEL GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 373. ITALY GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 374. ITALY GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 375. ITALY GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 376. ITALY GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 377. ITALY GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 378. ITALY GENE SYNTHESIS MARKET SIZE, BY METHOD, 2